SEC FORM 3

SEC FORM 3SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Abrams Therese Marie

(Last)

(First)

(Middle)

C/O SCHRODINGER, INC

1540 BROADWAY, 24TH FLOOR

(Street)

NEW YORK

10036

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/08/2026

3. Issuer Name and Ticker or Trading Symbol
Schrodinger, Inc. [ SDGR ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Corporate Controller

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	19,461⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	⁽²⁾	01/30/2029	Common Stock	3,067	$4.34	D
Stock Option (right to buy)	⁽³⁾	02/04/2030	Common Stock	6,688	$17	D
Stock Option (right to buy)	⁽⁴⁾	02/27/2031	Common Stock	6,200	$102.48	D
Stock Option (right to buy)	⁽⁵⁾	02/09/2032	Common Stock	15,000	$27.76	D
Stock Option (right to buy)	⁽⁶⁾	02/09/2033	Common Stock	5,000	$23.29	D
Stock Option (right to buy)	⁽⁷⁾	03/04/2034	Common Stock	3,398	$25.24	D
Stock Option (right to buy)	⁽⁸⁾	03/03/2035	Common Stock	5,526	$21.24	D
Stock Option (right to buy)	⁽⁹⁾	03/02/2036	Common Stock	5,980	$12.15	D

Explanation of Responses:

1. Includes 15,195 unvested restricted stock units ("RSUs"), comprised of 850 unvested RSUs that will vest on February 9, 2027, (ii) 2,549 unvested RSUs that will vest in equal installments on each of March 5, 2027 and 2028, (iii) 4,836 unvested RSUs that will vest in equal installments on each of March 4, 2027, 2028 and 2029 and (iv) 6,960 unvested RSUs that will vest in equal installments on each of March 9, 2027, 2028, 2029 and 2030, in each case, subject to the Reporting Person's continued service with the company. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

2. The option was granted on January 30, 2019 and is fully vested.

3. The option was granted on February 5, 2020 and is fully vested.

4. The option was granted on February 27, 2021 and is fully vested.

5. The option was granted on February 9, 2022 and is fully vested.

6. The option was granted on February 9, 2023. The shares underlying the option vested with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

7. The option was granted on March 4, 2024. The shares underlying the option vested with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.

8. The option was granted on March 3, 2025. The shares underlying the option vested with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.

9. The option was granted on March 2, 2026. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 2, 2027 and the remainder are scheduled to vest in equal monthly installments through March 2, 2030.

Remarks:

1. This Form 3 is being filed late due to an administrative delay in obtaining the reporting person's EDGAR codes. This late filing is not due to any error of the reporting person. 2. Exhibit 24.1 Power of Attorney

	/s/ Donald Shum, as attorney-in-fact for Therese Abrams	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

SEC Form 3 filed by new insider Abrams Therese Marie